ClinicalTrials.gg
CompletedNCT07873658Updated Oct 14, 2026

Pathways 2 Safety: AI-Simulated Clients for Experiential Learning in Behavioral Health Education

An interventional study of Lethal means counseling training and skills practice in Lethal Means Counseling Skill, sponsored by University of Washington. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by University of Washington · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2026, registered Sep 2026).
Updated Oct 14, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study was to compare the effectiveness of practicing lethal means counseling skills with an artificial intelligence (AI)-powered client compared to practice with a live actor.

Read the detailed description

This project will bring Pathways 2 Safety (P2S) to UW social work (undergraduate and graduate) nursing (graduate) students. P2S is a 3-hour interdisciplinary training to teach clinicians to have firearm safety conversations with clients. After the training, students will be randomized to practice counseling skills using either AI-based clients or trained standardized clients (i.e., live actor) to compare the two practice modalities.

AI-based clients include a coaching agent that provides individualized feedback. Standardized client encounters will have parallel debriefing protocols. We will have three main evaluation outcomes: (1) effectiveness through pre/post surveys and observed standardized client assessments, (2) modality acceptability based on student engagement and feedback and (3) pragmatic comparison of modality time and cost.

Because participation is voluntary, this project provides a low-stakes opportunity to examine the educational value and acceptability of AI-supported learning relative to traditional methods, generating evidence to inform responsible, scalable use of AI across UW.

02

Conditions studied

  • Lethal Means Counseling Skill

Browse trials for

Keywords

  • suicide
  • firearms
  • counseling skill
  • artificial intelligence
03

In context

Suicide

714 studies on the registry are indexed under Suicide; 184 are open to participants now.

This study's enrollment of 82 is below the median of 103 across 572 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

University of Washington is the lead sponsor of 1,431 studies on the registry; 226 are open to participants now.

Of its 158 completed or terminated interventional studies of FDA-regulated products, 136 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • In a clinical degree program at the University of Washington

Exclusion criteria

Exclusion Criteria:

  • No university-based email address
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Practice with AI

    Students in this arm practice lethal means counseling skills with an AI-powered client

    Other: Lethal means counseling training and skills practice

  • Active comparator
    Practice with live actor

    Students in this arm practice lethal means counseling skills with a live actor

    Other: Lethal means counseling training and skills practice

  • No intervention
    No practice

    Students in this arm do not practice lethal means counseling skills

Interventions

  • OtherLethal means counseling training and skills practice

    P2S is a 3-hour interdisciplinary training to teach clinicians to have firearm safety conversations with clients. After the training, students will be randomized to practice counseling skills using either AI-based clients or trained standardized clients (i.e., live actor) to compare the two practice modalities, compared with no practice.

06

What researchers measure

Primary outcomes

  1. Lethal means counseling skills

    The primary outcome is lethal means counseling skills as observed and rated by reviewers then calculated as a percent out of 100, where 100% is a perfect score.

    Time frame: 2-4 weeks after baseline lethal means counseling assessment

Secondary outcomes

  1. Knowledge about lethal means counseling

    6-item multiple choice survey questions scored 0-6 correct, where 6 is a perfect score

    Time frame: 1 week after completing P2S training

  2. Confidence to conduct lethal means counseling

    Five Likert-style questions (scored 1-4) assessing confidence performing specific lethal means counseling skills, where a lower score indicates stronger agreement

    Time frame: 1 week after completing P2S training

  3. Perceived value of AI-practice clients

    Likert-style self-rated perceived value (scored 1-4) of AI-practice clients for acquiring clinical skills, where a lower score indicates stronger agreement

    Time frame: 1 week after completing P2S training

  4. Comfort using AI to acquire clinical skills

    Likert-style self-rated (scored 1-4) comfort using AI practice clients to acquire clinical skills, where a lower score indicates stronger agreement

    Time frame: 1 week after completing P2S training

07

Study locations

1 site
  • University of Washington
    Seattle, Washington 98195, United States
08

References and documents

Study documents

  • Study protocol · Sep 30, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — Not possible to de-identify recordings used for data.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in May 2026, 1 month.

Of 353 non-industry interventional studies with no phase under Suicide, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 53. This study's 1 month is below that.

Counting every sponsor, half of 366 studies reached it within 30 months; a quarter within 14 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2026
First posted
Oct 14, 2026
StartActual
Apr 11, 2026
Primary completionActual
May 28, 2026
CompletionActual
Jun 1, 2026
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07873658
Responsible party
Kelsey Conrick (Postdoctoral Scholar, University of Washington) — Principal investigator
First posted
Oct 14, 2026
Start date
Apr 11, 2026
Primary completion
May 28, 2026
Completion
Jun 1, 2026
Last update
Oct 14, 2026

Study contacts

Kelsey Conrick, PhD, MPH
principal investigator · University of Washington

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion